As fellow reluctant diabetics know, Dr. Jeffrey Bluestone believes the results of his highly publicized type-1-diabetes/leukemia drug study have been exaggerated. (See here.) But this latest article from First Coast News suggests that even though the excitement surrounding the trial was overblown, there still might be human trials starting within a year. Very interesting. Granted, it’s true that leukemia patients are probably likely to put up with more complications than diabetics, considering the immediately life-threatening nature of their disease — but it’ll still be interesting to see where these trials lead.
